|
Volumn 374, Issue 26, 2016, Pages 2604-2605
|
The authors reply
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARDIAC RESYNCHRONIZATION THERAPY;
CARDIOVASCULAR RISK;
CLINICAL EFFECTIVENESS;
DEVICE INFECTION;
HEART ATRIUM PACING;
HEART FAILURE;
HUMAN;
INFECTION RISK;
LEADLESS INTRACARDIAC TRANSCATHETER PACING SYSTEM;
LETTER;
PACEMAKER;
PRIORITY JOURNAL;
RISK REDUCTION;
VEIN OCCLUSION;
ARRHYTHMIAS, CARDIAC;
ARTIFICIAL HEART PACEMAKER;
FEMALE;
MALE;
ARRHYTHMIAS, CARDIAC;
FEMALE;
HUMANS;
MALE;
PACEMAKER, ARTIFICIAL;
|
EID: 84976510715
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1604852 Document Type: Letter |
Times cited : (47)
|
References (2)
|